n-methyl-3,4-methylenedioxyamphetamine has been researched along with n,n-dimethyl-2-(2-amino-4-cyanophenylthio)benzylamine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dannals, RF; Mathews, WB; McCann, UD; Ravert, HT; Ricaurte, GA; Rosenblatt, P; Seckin, E; Szabo, Z | 1 |
| Andreasen, MF; Benda, K; Cumming, P; Gramsbergen, JB; Jakobsen, S; Jensen, SB; Minuzzi, L; Møller, M; Olsen, AK; Pakkenberg, B; Stark, AK | 1 |
| Boileau, I; Collins, DL; Furukawa, Y; Guttman, M; Houle, S; Kish, SJ; Lerch, J; McCluskey, T; Meyer, J; Mundo, E; Rusjan, PM; Saint-Cyr, JA; Shapiro, C; Tong, J; Warsh, JJ; Wilkins, D; Wilson, AA | 1 |
| Abi-Dargham, A; Frankle, WG; Girgis, RR; Hart, CL; Kegeles, LS; Laruelle, M; Slifstein, M; Talbot, PS; Urban, NB; Xu, X | 1 |
1 trial(s) available for n-methyl-3,4-methylenedioxyamphetamine and n,n-dimethyl-2-(2-amino-4-cyanophenylthio)benzylamine
| Article | Year |
|---|---|
Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB.
Topics: Adult; Benzylamines; Brain; Carbon Radioisotopes; Demography; Female; Hallucinogens; Humans; Image Processing, Computer-Assisted; Isoquinolines; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; Membrane Transport Proteins; Models, Statistical; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Positron-Emission Tomography; Protein Binding; Radioligand Assay; Radiopharmaceuticals; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Statistics as Topic | 2005 |
3 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and n,n-dimethyl-2-(2-amino-4-cyanophenylthio)benzylamine
| Article | Year |
|---|---|
A PET study of effects of chronic 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on serotonin markers in Göttingen minipig brain.
Topics: Animals; Benzylamines; Binding, Competitive; Brain; Brain Mapping; Carbon Radioisotopes; Female; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Positron-Emission Tomography; Pyridines; Serotonin; Serotonin Agents; Serotonin Antagonists; Swine; Swine, Miniature; Tissue Distribution | 2007 |
Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.
Topics: Adult; Amphetamine-Related Disorders; Benzylamines; Brain; Carbon Radioisotopes; Cerebral Cortex; Chronic Disease; Female; Hallucinogens; Hormones; Humans; Magnetic Resonance Imaging; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Serotonin Plasma Membrane Transport Proteins; Sleep; Surveys and Questionnaires | 2010 |
Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.
Topics: Adult; Amphetamine-Related Disorders; Benzylamines; Brain Mapping; Carbon Radioisotopes; Female; Fluorobenzenes; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neocortex; Piperidines; Positron-Emission Tomography; Protein Binding; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Serotonin Plasma Membrane Transport Proteins; Young Adult | 2012 |